Search

BRIDGEWATER, N.J., May 30, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, will host [...]

BRIDGEWATER, N.J., May 30, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

-Additional Data from ARISE Study Evaluating the Impact of ARIKAYCE on Microbiologic Outcomes in Patients with Newly Diagnosed or Recurrent MAC Lung Disease to be Presented as Late-Breaker- -Data to [...]

-Data from Retrospective Study Evaluating the Association Between Hospitalization Burden and Delay in Diagnosis of Nontuberculous Mycobacterial (NTM) Lung Disease Among Patients with Chronic Obstructive Pulmonary Disease (COPD) to Be [...]

DUBLIN, Dec. 1, 2021 /PRNewswire/ -- The 'Cardiovascular Drug Delivery - Technologies, Markets & Companies' report from Jain PharmaBiotech has been added toResearchAndMarkets.com's offering. The cardiovascular drug delivery markets are [...]

Draft label contains both PAH and PH-ILD indications; no contraindications and no boxed warning Complete response cites an open inspection issue at a third-party analytical testing facility; no other deficiencies [...]

FDA action expected in October 2021 SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 16, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food [...]

- Tyvaso DPI includes the second compound formulated with MannKind's Technosphere technology to be reviewed by the FDA - FDA review expected to be complete in October 2021 - Hiring [...]

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 7, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it is pursuing additional claims for trade secret misappropriation [...]

First pivotal study of Tyvaso (treprostinil) Inhalation Solution outside pulmonary hypertension SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 3, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced [...]

FinancialNewsMedia.com News Commentary PALM BEACH, Fla., May 12, 2021 /PRNewswire/ -- Autism spectrum disorder (ASD) represents a group of neurodevelopmental disorders or disabilities; it is a heritable and a polygenic [...]

NDA submission includes both pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease indications Priority review voucher applied to the NDA submission SILVER SPRING, Md. and RESEARCH TRIANGLE [...]

First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need FDA approval based on data [...]

--Call Scheduled for Friday, February 19, 2021, at 8:30 a.m. ET-- BRIDGEWATER, N.J., Feb. 16, 2021 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to [...]

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 10, 2021 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it has launched commercial sales of the innovative Remunity [...]

Study demonstrated safety and tolerability of Tyvaso DPI(TM) in patients with PAH transitioning from Tyvaso Inhalation Solution A separate study in healthy volunteers demonstrated comparable treprostinil exposure between Tyvaso DPI [...]

INCREASE Study is First to Demonstrate a Clear Benefit in Patients with PH-ILD, a Life-threatening Disease with No Currently FDA-Approved Treatments Company to host a webcast detailing the INCREASE study [...]

Clinical study data suggests Tyvaso improved forced vital capacity, an important measure of lung function, in patients with pulmonary hypertension associated with interstitial lung disease Seven poster presentations are available [...]

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced it will present clinical trial data on Tyvaso(treprostinil) Inhalation Solution [...]

BRIDGEWATER, N.J., Oct. 2, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

- Initiated Phase 1 study of treprostinil palmitil inhalation powder (TPIP); Phase 2a study in pulmonary arterial hypertension planned for 2021 - - Expects to initiate registrational Phase 3 ASPEN [...]

BRIDGEWATER, N.J., Sept. 16, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

BRIDGEWATER, N.J., Sept. 9, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

BRIDGEWATER, N.J., Sept. 4, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) today announced that the U.S. Food and Drug Administration (FDA) accepted for [...]

The Profit will Increase by about 150% Over the Same Period HONG KONG, Aug. 14, 2020 /PRNewswire/ --Lee's Pharmaceutical Holdings Limited ('Lee's Pharm ' or the 'Group ',Stock Code: 950), [...]

BRIDGEWATER, N.J., Aug. 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

--First update to treatment guidelines in more than a decade, marking important milestone in patient care-- --Guidelines recognize importance of ARIKAYCE in addressing significant unmet need-- BRIDGEWATER, N.J., July 7, [...]

BRIDGEWATER, N.J., July 6, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., June 17, 2020 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that key data from the INCREASE study of Tyvaso(treprostinil) Inhalation [...]

--Full Results from Phase 2 WILLOW Study of Brensocatib in NCFBE to be Presented at Virtual ATS Session on June 24, 2020-- BRIDGEWATER, N.J., June 8, 2020 /PRNewswire/ -- Insmed [...]

BRIDGEWATER, N.J., June 5, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

BRIDGEWATER, N.J., May 26, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

NASDAQ: CORV TSX: CORV VANCOUVER, May 21, 2020 /PRNewswire/ - Correvio Pharma Corp. (' Correvio ' or the 'Company ') (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on [...]

BRIDGEWATER, N.J., May 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today the closing of the previously announced public offering of 11,155,000 shares of its common stock, including 1,455,000 [...]

BRIDGEWATER, N.J., May 7, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

NASDAQ: CORV TSX: CORV VANCOUVER, May 6, 2020 /PRNewswire/ - Correvio Pharma Corp. ('Correvio' or the 'Company') (NASDAQ: CORV) (TSX: CORV), today announced that Glass, Lewis & Co., LLC ('Glass [...]

BRIDGEWATER, N.J., May 5, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it priced a registered underwritten public offering of 9,700,000 shares of its common stock at a [...]

BRIDGEWATER, N.J., May 4, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM) announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. [...]

NASDAQ: CORV TSX: CORV VANCOUVER, May 1, 2020 /PRNewswire/ - Correvio Pharma Corp. ('Correvio' or the 'Company') (NASDAQ: CORV) (TSX: CORV), today announced that Institutional Shareholder Services Inc. ('ISS'), a [...]

- Orenitram demonstrated improvement in hemodynamic parameters and risk status, important indicators of long-term outcomes in PAH patients, in presentations at recent scientific conferences - Separately, total PAH-related patient healthcare [...]

--Insmed to support STOP-COVID19 Study, Expected to Begin in the UK in May 2020-- BRIDGEWATER, N.J., April 23, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a [...]

NASDAQ: CORV TSX: CORV VANCOUVER, April 8, 2020 /PRNewswire/ - Correvio Pharma Corp. (' Correvio ' or the 'Company ') (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on [...]

Panel of 19 Physicians Provided Consensus Opinions on Clinical Scenarios in Which They Considered Adding Oral PPAs in Patients with PAH on ERA + PDE-5 Inhibitor Background Therapy SOUTH SAN [...]

BRIDGEWATER, N.J., April 3, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today [...]

BRIDGEWATER, N.J., April 2, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected to [...]

NASDAQ: CORVTSX: CORV VANCOUVER and HONG KONG, March 10, 2020 /PRNewswire/ - Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, and Hong [...]

BRIDGEWATER, N.J., March 5, 2020 /PRNewswire/ -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

NASDAQ: CORV TSX: CORV VANCOUVER, March 2, 2020 /PRNewswire/ - At the request of Investment Industry Regulatory Organization of Canada ('IIROC'), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the 'Company') [...]